Adrian A. Pace
Salford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 04, 2024
Identifying co-morbidities and risk in people with epilepsy: The Maltese experience.
Journal: Epilepsy & behavior : E&B
Published: December 09, 2023
Amantadine toxicity causing visual hallucinations.
Journal: Practical neurology
Published: June 20, 2023
Genetic landscape of ALS in Malta based on a quinquennial analysis.
Journal: Neurobiology of aging
Published: August 29, 2022
SOD1 D91A variant in the southernmost tip of Europe: a heterozygous ALS patient resident on the island of Gozo.
Journal: European journal of human genetics : EJHG
Published: August 08, 2021
Progressive encephalomyelitis with rigidity and myoclonus (PERM).
Journal: Practical neurology
Published: July 07, 2021
Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: April 06, 2021
Eslicarbazepine acetate response in intellectual disability population versus general population.
Journal: Acta neurologica Scandinavica
Published: September 08, 2020
Lacosamide in the general population and in people with intellectual disability: Similar responses?
Journal: Seizure
Published: January 14, 2020
Neurosarcoidosis associated with intracerebral haemorrhage: a challenge in diagnosis and management.
Neurosarcoidosis associated with intracerebral haemorrhage: a challenge in diagnosis and management.
Journal: Practical neurology
Published: December 30, 2017
A subarachnoid haemorrhage-specific outcome tool.
Journal: Brain : a journal of neurology
Published: July 06, 2017
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 20, 2017
Last Updated: 09/26/2026